The ATOM Coalition’s new case studies examine cancer care financing in Georgia, Kenya, the Philippines, and Zambia, offering policy insights to strengthen access in low- and middle-income countries.
The Access to Oncology Medicines (ATOM) Coalition, led by the Union for International Cancer Control (UICC), has released its first Health Financing Case Studies series. Focusing on Georgia, Kenya, the Philippines, and Zambia, these studies explore how low- and lower-middle-income countries (LLMICs) are financing cancer care within broader efforts toward universal health coverage (UHC). With high out-of-pocket costs limiting access to oncology medicines, the studies provide policy recommendations to strengthen sustainable financing systems for essential cancer medicines and diagnostics.
This initiative comes as cancer deaths are projected to rise in LMICs, with 75% of global cancer-related deaths expected to occur in these regions by 2030. The case studies identify both best practices and gaps in financing strategies, serving as a guide for policymakers and health partners to develop more equitable access pathways.
The launch marks a critical step in shaping evidence-based financing strategies to address the growing cancer burden in LLMICs. As Sarbani Chakraborty, Technical Advisor for Health Financing at ATOM Coalition, emphasised, “Cancer is a global crisis, but its burden is not shared equally.” The insights aim to drive sustainable solutions for oncology care financing.
